{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:37:04Z","timestamp":1789663024663,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T00:00:00Z","timestamp":1513123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s13318-017-0453-7","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:11:27Z","timestamp":1730974287000},"page":"311-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3872-5771","authenticated-orcid":false,"given":"Maaike A.","family":"Sikma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7843-6208","authenticated-orcid":false,"given":"Claudine C.","family":"Hunault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Kirkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3276-6428","authenticated-orcid":false,"given":"Marianne C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Kesecioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0191-7270","authenticated-orcid":false,"given":"Dylan W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,13]]},"reference":[{"key":"453_CR1","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.healun.2012.08.002","volume":"31","author":"J Stehlik","year":"2012","unstructured":"Stehlik J, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dipchand AI, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report\u20132012. J Heart Lung Transpl. 2012;31:1052\u201364.","journal-title":"J Heart Lung Transpl"},{"key":"453_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/TP.0b013e318277e378","volume":"95","author":"S Guethoff","year":"2013","unstructured":"Guethoff S, Meiser BM, Groetzner J, Eifert S, Grinninger C, Ueberfuhr P, et al. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation. Transplantation. 2013;95:629\u201334.","journal-title":"Transplantation"},{"key":"453_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00228-010-0902-6","volume":"66","author":"L Penninga","year":"2010","unstructured":"Penninga L, M\u00f8ller CH, Gustafsson F, Steinbr\u00fcchel DA, Gluud C. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur J Clin Pharmacol. 2010;66:1177\u201387.","journal-title":"Eur J Clin Pharmacol"},{"key":"453_CR4","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/tri.12503","volume":"28","author":"LE Zijlstra","year":"2015","unstructured":"Zijlstra LE, Constantinescu AA, Manintveld O, Birim O, Hesselink DA, van Thiel R, et al. Improved long-term survival in Dutch heart transplant patients despite increasing donor age: the Rotterdam experience. Transpl Int. 2015;28:962\u201371.","journal-title":"Transpl Int"},{"key":"453_CR5","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/TP.0000000000001243","volume":"100","author":"BJ Nankivell","year":"2016","unstructured":"Nankivell BJ, P\u2019Ng CH, O\u2019Connell PJ, Chapman JR. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras. Transplantation. 2016;100:1723\u201331.","journal-title":"Transplantation"},{"key":"453_CR6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.healun.2013.08.006","volume":"32","author":"LH Lund","year":"2013","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, Dipchand AI, Benden C, Christie JD, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtieth official adult heart transplant report-2013; focus theme: age. J Heart Lung Transpl. 2013;32:951\u201364.","journal-title":"J Heart Lung Transpl"},{"key":"453_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.healun.2015.07.007","volume":"35","author":"AH Healy","year":"2016","unstructured":"Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman CH. Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices\u2014an analysis of the International Society for Heart and Lung Transplantation Transplant Registry. J Heart Lung Transpl. 2016;35:34\u20139.","journal-title":"J Heart Lung Transpl"},{"key":"453_CR8","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","volume":"34","author":"LH Lund","year":"2015","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second Official Adult Heart Transplantation Report-2015; focus theme: early graft failure. J Heart Lung Transpl. 2015;34:1244\u201354.","journal-title":"J Heart Lung Transpl"},{"key":"453_CR9","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/tri.12710","volume":"29","author":"C S\u00f6derlund","year":"2016","unstructured":"S\u00f6derlund C, L\u00f6fdahl E, Nilsson J, Reitan \u00d6, Higgins T, R\u00e5degran G. Chronic kidney disease after heart transplantation: a single-centre retrospective study at Sk\u00e5ne University Hospital in Lund 1988\u20132010. Transpl Int. 2016;29:529\u201339.","journal-title":"Transpl Int"},{"key":"453_CR10","first-page":"1355","volume":"40","author":"LS De Santo","year":"2011","unstructured":"De Santo LS, Romano G, Amarelli C, Maiello C, Baldascino F, Bancone C, et al. Implications of acute kidney injury after heart transplantation: what a surgeon should know. Eur J Cardiothorac Surg. 2011;40:1355\u201361 (Oxford University Press; discussion1361).","journal-title":"Eur J Cardiothorac Surg."},{"key":"453_CR11","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00467-015-3252-x","volume":"31","author":"C MacDonald","year":"2016","unstructured":"MacDonald C, Norris C, Alton GY, Urschel S, Joffe AR, Morgan CJ, et al. Acute kidney injury after heart transplant in young children: risk factors and outcomes. Pediatr Nephrol. 2016;31:671\u20138 (Springer Berlin Heidelberg).","journal-title":"Pediatr Nephrol"},{"key":"453_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.transproceed.2015.12.006","volume":"48","author":"R Tjahjono","year":"2016","unstructured":"Tjahjono R, Connellan M, Granger E. Predictors of acute kidney injury in cardiac transplantation. Transpl Proc. 2016;48:167\u201372.","journal-title":"Transpl Proc"},{"key":"453_CR13","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1111\/j.1399-0012.2010.01225.x","volume":"24","author":"E Gude","year":"2010","unstructured":"Gude E, Andreassen AK, Arora S, Gullestad L, Grov I, Hartmann A, et al. Acute renal failure early after heart transplantation: risk factors and clinical consequences. Clin Transpl. 2010;24:E207\u201313 (Blackwell Publishing Ltd).","journal-title":"Clin Transpl"},{"key":"453_CR14","doi-asserted-by":"publisher","first-page":"E194","DOI":"10.1111\/j.1399-0012.2010.01249.x","volume":"24","author":"JF Delgado","year":"2010","unstructured":"Delgado JF, Crespo-Leiro MG, G\u00f3mez-S\u00e1nchez MA, Paniagua MJ, Gonz\u00e1lez-V\u00edlchez F, V\u00e1zquez de Prada JA, et al. Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: results from the CAPRI study. Clin Transpl. 2010;24:E194\u2013200.","journal-title":"Clin Transpl"},{"key":"453_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"453_CR16","first-page":"2388","volume":"36","author":"W Aidong","year":"2004","unstructured":"Aidong W, Zhenjie C, Tong L, Lei Z, Yin W, Shanqi Z, et al. Therapeutic drug monitoring of tacrolimus in early stage after heart transplantation. TPS. 2004;36:2388\u20139.","journal-title":"TPS."},{"key":"453_CR17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0009-9120(00)00163-6","volume":"33","author":"P Salm","year":"2000","unstructured":"Salm P, Rutherford DM, Taylor PJ, Black MJ, Pillans PI. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients. Clin Biochem. 2000;33:557\u201362.","journal-title":"Clin Biochem"},{"issue":"4","key":"453_CR18","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384 (Karger Publishers).","journal-title":"Nephron Clin Pract."},{"key":"453_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nrneph.2017.2","volume":"13","author":"LS Chawla","year":"2017","unstructured":"Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, et al. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol. 2017;13:241\u201357 (Nature Publishing Group).","journal-title":"Nat Rev Nephrol."},{"key":"453_CR20","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312 (NIH Public Access).","journal-title":"Ann Intern Med"},{"key":"453_CR21","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","volume":"41","author":"U Christians","year":"2002","unstructured":"Christians U, Jacobsen W, Benet LZ, Lampen A. Mechanisms of clinically relevant drug interactions associated with tacrolimus. Clin Pharmacokinet. 2002;41:813\u201351 (Springer International Publishing).","journal-title":"Clin Pharmacokinet"},{"key":"453_CR22","first-page":"1099-e7","volume":"35","author":"L Kramer","year":"2007","unstructured":"Kramer L, Jordan B, Druml W, Bauer P, Metnitz PGH. Incidence and prognosis of early hepatic dysfunction in critically ill patients\u2014a prospective multicenter study. Crit Care Med. 2007;35:1099-e7.","journal-title":"Crit Care Med"},{"key":"453_CR23","first-page":"580","volume":"2013","author":"RP Dellinger","year":"2012","unstructured":"Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2012;2013:580\u2013637.","journal-title":"Crit Care Med"},{"key":"453_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2307\/2531248","volume":"42","author":"SL Zeger","year":"1986","unstructured":"Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121\u201330.","journal-title":"Biometrics"},{"key":"453_CR25","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00228-017-2204-8","volume":"73","author":"MA Sikma","year":"2017","unstructured":"Sikma MA, Hunault CC, van de Graaf EA, Verhaar MC, Kesecioglu J, de Lange DW, et al. High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury. Eur J Clin Pharmacol. 2017;73:573\u201380 (Springer Berlin Heidelberg).","journal-title":"Eur J Clin Pharmacol"},{"key":"453_CR26","doi-asserted-by":"publisher","first-page":"e2025","DOI":"10.1097\/MD.0000000000002025","volume":"94","author":"J-R Xu","year":"2015","unstructured":"Xu J-R, Zhu J-M, Jiang J, Ding X-Q, Fang Y, Shen B, et al. Risk factors for long-term mortality and progressive chronic kidney disease associated with acute kidney injury after cardiac surgery. Medicine (Baltimore). 2015;94:e2025.","journal-title":"Medicine (Baltimore)"},{"key":"453_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000322161","volume":"31","author":"F Garzotto","year":"2011","unstructured":"Garzotto F, Piccinni P, Cruz D, Gramaticopolo S, Dal Santo M, Aneloni G, et al. RIFLE-based data collection\/management system applied to a prospective cohort multicenter italian study on the epidemiology of acute kidney injury in the intensive care unit. Blood Purif. 2011;31:159\u201371.","journal-title":"Blood Purif"},{"key":"453_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.12659\/AOT.889103","volume":"18","author":"JM Lee","year":"2013","unstructured":"Lee JM, Lee S-A, Cho H-J, Yang H-M, Lee H-Y, Hwang HY, et al. Impact of perioperative renal dysfunction in heart transplantation: combined heart and kidney transplantation could help to reduce postoperative mortality. Ann Transpl. 2013;18:533\u201349.","journal-title":"Ann Transpl"},{"key":"453_CR29","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1681\/ASN.V11122315","volume":"11","author":"S Hortelano","year":"2000","unstructured":"Hortelano S, Castilla M, Torres AM, Tejedor A, Bosc\u00e1 L. Potentiation by nitric oxide of cyclosporin A and FK506-induced apoptosis in renal proximal tubule cells. J Am Soc Nephrol. 2000;11:2315\u201323.","journal-title":"J Am Soc Nephrol"},{"key":"453_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/01.TP.0000128613.74683.D9","volume":"78","author":"BJ Nankivell","year":"2004","unstructured":"Nankivell BJ, Borrows RJ, Fung CLS, Oconnell PJ, Chapman JR, Allen RDM. Delta analysis of posttransplantation tubulointerstitial damage. Transplantation. 2004;78:434\u201341.","journal-title":"Transplantation"},{"key":"453_CR31","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","volume":"22","author":"C Esteva-Font","year":"2007","unstructured":"Esteva-Font C, Ars E, Guillen-Gomez E, Campistol JM, Sanz L, Jimenez W, et al. Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2). Nephrol Dial Transpl. 2007;22:2810\u20136.","journal-title":"Nephrol Dial Transpl"},{"key":"453_CR32","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1093\/hmg\/ddi238","volume":"14","author":"P Catarsi","year":"2005","unstructured":"Catarsi P. Angiotensin-converting enzyme (ACE) haplotypes and cyclosporine A (CsA) response: a model of the complex relationship between ACE quantitative trait locus and pathological phenotypes. Hum Mol Genet. 2005;14:2357\u201367.","journal-title":"Hum Mol Genet"},{"key":"453_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00000478-199301000-00007","volume":"17","author":"PS Randhawa","year":"1993","unstructured":"Randhawa PS, Shapiro R, Jordan ML, Starzl TE, Demetris AJ. The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Am J Surg Pathol. 1993;17:60\u20138.","journal-title":"Am J Surg Pathol"},{"key":"453_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1592\/phco.30.2.195","volume":"30","author":"JPF Bai","year":"2010","unstructured":"Bai JPF, Lesko LJ, Burckart GJ. Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors. Pharmacotherapy. 2010;30:195\u2013209.","journal-title":"Pharmacotherapy"},{"key":"453_CR35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481\u2013508.","journal-title":"Clin J Am Soc Nephrol"},{"key":"453_CR36","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1097\/01.tp.0000185303.92981.d6","volume":"80","author":"BH Ozdemir","year":"2005","unstructured":"Ozdemir BH, Ozdemir FN, Demirhan B, Haberal M. TGF-beta1 expression in renal allograft rejection and cyclosporine A toxicity. Transplantation. 2005;80:1681\u20135.","journal-title":"Transplantation"},{"key":"453_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM198409133111103","volume":"311","author":"BD Myers","year":"1984","unstructured":"Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984;311:699\u2013705.","journal-title":"N Engl J Med"},{"key":"453_CR38","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell BJ, Borrows RJ, Fung CLS, O\u2019Connell PJ, Allen RDM, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med. 2003;349:2326\u201333.","journal-title":"N Engl J Med"},{"key":"453_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.recesp.2010.05.001","volume":"64","author":"IJ S\u00e1nchez-L\u00e1zaro","year":"2011","unstructured":"S\u00e1nchez-L\u00e1zaro IJ, Almenar Bonet L, Mart\u00ednez-Dolz L, Buend\u00eda Fuentes F, Navarro-Manch\u00f3n J, Ag\u00fcero Ramon-Llin J, et al. Repeated daclizumab administration to delay the introduction of calcineurin inhibitors in heart transplant patients with postoperative renal dysfunction. Rev Esp Cardiol. 2011;64:237\u20139.","journal-title":"Rev Esp Cardiol"},{"key":"453_CR40","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.healun.2008.07.020","volume":"27","author":"F Gonz\u00e1lez-V\u00edlchez","year":"2008","unstructured":"Gonz\u00e1lez-V\u00edlchez F, de Prada JAV, Exposito V, Garc\u00eda-Camarero T, Fern\u00e1ndez-Friera L, Llano M, et al. Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure. J Heart Lung Transpl. 2008;27:1135\u201341.","journal-title":"J Heart Lung Transpl"},{"key":"453_CR41","first-page":"277","volume":"32","author":"I Kaczmarek","year":"2013","unstructured":"Kaczmarek I, Zaruba M-M, Beiras-Fernandez A, Reimann R, Nickel T, Grinninger C, et al. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus\/mycophenolate mofetil) after heart transplantation: 5-year results. HEALUN. 2013;32:277\u201384 (Elsevier).","journal-title":"HEALUN"},{"key":"453_CR42","first-page":"259","volume":"31","author":"S Arora","year":"2012","unstructured":"Arora S, Gude E, Sigurdardottir V, Mortensen SA, Eiskj\u00e6r H, Riise G, et al. Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: The significance of baseline glomerular filtration rate. HEALUN. 2012;31:259\u201365 (Elsevier Inc).","journal-title":"HEALUN."},{"key":"453_CR43","first-page":"1581","volume":"90","author":"L Gullestad","year":"2010","unstructured":"Gullestad L, Mortensen S-A, Eiskj\u00e6r H, Riise GC, Mared L, Bj\u00f8rtuft \u00d8, et al. Two-Year Outcomes in Thoracic Transplant Recipients After Conversion to Everolimus With Reduced Calcineurin Inhibitor Within a Multicenter, Open-Label. Randomized Trial. Transplantation. 2010;90:1581\u20139.","journal-title":"Randomized Trial. Transplantation."},{"key":"453_CR44","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.transproceed.2012.09.045","volume":"44","author":"E Kaplinsky","year":"2012","unstructured":"Kaplinsky E, Gonz\u00e1lez-Costello J, Manito N, Roca J, Barbosa MJ, Nebot M, et al. Renal function improvement after conversion to proliferation signal inhibitors during long-term follow-up in heart transplant recipients. Transpl Proc. 2012;44:2564\u20136.","journal-title":"Transpl Proc"},{"key":"453_CR45","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/ctr.12269","volume":"27","author":"JT Thibodeau","year":"2013","unstructured":"Thibodeau JT, Mishkin JD, Patel PC, Kaiser PA, Ayers CR, Mammen PPA, et al. Tolerability of sirolimus: a decade of experience at a single cardiac transplant center. Clin Transpl. 2013;27:945\u201352.","journal-title":"Clin Transpl"},{"key":"453_CR46","doi-asserted-by":"publisher","first-page":"310","DOI":"10.5500\/wjt.v5.i4.310","volume":"5","author":"N Manito","year":"2015","unstructured":"Manito N, Delgado JF, Crespo-Leiro MG, Ariz\u00f3n JM, Segovia J, Gonz\u00e1lez-V\u00edlchez F, et al. Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients. World J Transpl. 2015;5:310\u20139.","journal-title":"World J Transpl"},{"key":"453_CR47","doi-asserted-by":"publisher","first-page":"R108","DOI":"10.1186\/cc12777","volume":"17","author":"G Bragadottir","year":"2013","unstructured":"Bragadottir G, Redfors B, Ricksten S-E. Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury\u2014true GFR versus urinary creatinine clearance and estimating equations. Crit Care. 2013;17:R108.","journal-title":"Crit Care"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-017-0453-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-017-0453-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-017-0453-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:11:30Z","timestamp":1730974290000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-017-0453-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,13]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s13318-017-0453-7","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,13]]},"assertion":[{"value":"13 December 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was conducted in compliance with the Declaration of Helsinki, Good Clinical Practice guidelines and in accordance with local and national regulatory requirements and laws. The accredited ethics committee of the University Medical Center Utrecht has approved of the use of patient data (IRB UMC Utrecht\u00a0protocol number 12-071).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Claudine C. Hunault, Marianne C. Verhaar, Johannes H. Kirkels, Jozef Kesecioglu and Dylan W. de Lange declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of interest"}},{"value":"No source of funding\u00a0was used to conduct this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}